Journal of Oncology Research and Treatment
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Oncol Res Treat
  • DOI: 10.4172/aot.s4.1000e001

Editor's Note on Journal of Oncology Research and Treatment: Open Access by Peifeng Li

Peifeng Li*
Department of Medicine Qingdao University, Qingdao, China
*Corresponding Author: Peifeng Li, Department of Medicine Qingdao University, Qingdao, China, Email: peifli@qdu.edu.cn

Received: 06-Jan-2021 / Accepted Date: 20-Jan-2021 / Published Date: 27-Jan-2021 DOI: 10.4172/aot.s4.1000e001

Keywords: carcinoma

Editorial Note

I am pleased to mention that during the year 2020, all issues of volume 5 were published online well within the time and the print issues were also brought out and dispatched within 30 days of publishing the issue online.

Our greatest strength lies in the gold open access mode of publishing enabling the content accessible to the remotest corners of the world absolutely free of charge. The constituent journals, mentored by an internationally acclaimed editorial team regularly publish peer reviewed content in all formats of scientific reporting covering major specializations of clinical and medical science. Consequently our journal productions appear in several indexing databases and are very popular among academicians, researchers, students, medical and pharmaceutical industry.

AOT sets the standards for the Cancer research and therapy, by publishing the latest innovations as research articles, review articles, case studies, short communication, commentaries and the letters to the editor.

Reviewers can access, read and download full length manuscript and submit their opinions. Editors can oversee and operate the entire cycle of screening, revisions, editing of the submissions. Publishers can monitor the submissions and channelize production operations such as copy editing, style sheet implementation and author proof generation.

AOT caters to the requirements of wide spectrum of researchers who are clinical practitioners, diagnostic professionals, medical practitioners, pharmacists, chemists and druggists and the institutions engaged in academic and research practices in Cancer research and therapy.

The submissions to the journal are subjected to peer-review process by the editorial board members or external subject experts. The complete editorial processing of the manuscript is done through the integrated online editorial manuscript submission and review system for greater transparency and faster article throughout.

We have applied many strategies in 2020, i.e.

•Using contacting through Mobile (What’s app) phones •Sent Call for papers for the eminent in the field •Approaching the Editors suggested eminent Research fields •Approaching potential reviewers for the Call for papers •Maintaining the frequency of articles.

We have applying many new strategies in 2021, adding new dimension i.e. releasing special issues in the volume 6 contacting researchers through LinkedIn, Twitter and Calls.

Conclusion

I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of AOT, the office bearers and staff for their support in bringing out yet another volume of AOT and look forward to their unrelenting support to bring out the Volume 6 of AOT in scheduled time.

Thank you!

Citation: Li P (2021) Editor’s Note: Journal of Oncology Research and Treatment: Open Access by Peifeng Li. J Oncol Res Treat S4: e001. DOI: 10.4172/aot.s4.1000e001

Copyright: © 2021 Li P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top